Dr. Meynen Femke - Reumatoloog
0730.818.388 · rovalta.com · 28/09/2026
ACTIVE
Dr. Meynen Femke - Reumatoloog
Financial year 2025 · Closed on 31/12/2025
Net result142 k €-25,0 %over 1 year
Gross margin203,7 k €-25,5 %over 1 year
Equity186,5 k €-11,7 %over 1 year
Overview
Identity
Source · BCE/KBODr. Meynen Femke - Reumatoloog is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Diest.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0730.818.388
- Incorporation
- 18/07/2019
- Legal form
- Private limited company
- Registered office
- Rothstraat 46
3290 Diest · FlandreSee on map - Contributed capital
- 1,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 203,7 k € | -25.5% | 273,2 k € | +66.7% | 163,9 k € | +30.8% | 125,3 k € | +49.3% | 83,9 k € |
| EBITDA | 197,4 k € | -27.6% | 272,7 k € | +69.3% | 161,1 k € | +32.0% | 122 k € | +46.1% | 83,5 k € |
| Operating result | 185,8 k € | -28.3% | 259 k € | +75.8% | 147,3 k € | +36.6% | 107,9 k € | +54.6% | 69,8 k € |
| Net result | 142 k € | -25.0% | 189,3 k € | +64.4% | 115,2 k € | +37.3% | 83,9 k € | +55.0% | 54,2 k € |
| Balance sheet | |||||||||
| Equity | 186,5 k € | -11.7% | 211,2 k € | +37.3% | 153,8 k € | -25.1% | 205,3 k € | +69.2% | 121,3 k € |
| Total assets | 268,4 k € | -22.0% | 344,2 k € | +53.5% | 224,2 k € | -5.7% | 237,6 k € | +38.7% | 171,4 k € |
| Cash | 169,6 k € | -32.6% | 251,7 k € | +60.0% | 157,3 k € | +73.3% | 90,8 k € | +45.4% | 62,4 k € |
| Debts | 81,9 k € | -38.4% | 133 k € | +89.1% | 70,4 k € | +117% | 32,4 k € | -35.3% | 50 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Femke Meynen | MandateDirectorended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 19/07/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 18 months |
| Filing date | 07/07/2026 | 14/09/2025 | 31/08/2024 | 31/08/2023 | 30/08/2022 | 05/08/2021 |
| General meeting | 10/06/2026 | 10/06/2025 | 06/06/2024 | 06/06/2023 | 06/06/2022 | 06/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 10/06/2026 | 07/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 10/06/2025 | 14/09/2025 | Dutch | |
| Micro model | 31/12/2023 | 06/06/2024 | 31/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 06/06/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 06/06/2022 | 30/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 06/06/2021 | 05/08/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Femke Meynen | MandateDirectorended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
20192020202120222023202420252026
Dr. Meynen Femke - Reumatoloog
Rothstraat 46, 3290 DiestMaastrichterweg 17, 3620 Lanaken
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rothstraat 46, 3290 DiestCurrent | accounts 2025 | Accounts 2025 · 2026-00268767 |
| Maastrichterweg 17, 3620 Lanaken | accounts 2021 → 2024 | Accounts 2024 · 2025-00490900 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Meynen Femke - ReumatoloogCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00268767 |
Events
- 2025Annual accounts 2025142 k €↓
- 2024Annual accounts 2024189,3 k €↑
- 2023Annual accounts 2023115,2 k €↑
- 2022Annual accounts 202283,9 k €↑
- 2021Annual accounts 202154,2 k €↓
- 2020Annual accounts 202067,2 k €
- 18/07/2019IncorporationPrivate limited company